Successful Opening of Ductus Arteriosus with Milrinone in a Newborn with Tetralogy of Fallot and Pulmonary Atresia
Journal of the Korean Society of Neonatology
;
: 365-369, 2011.
Artículo
en Inglés
| WPRIM
| ID: wpr-59455
ABSTRACT
Tetralogy of Fallot (TOF) assumes its' most severe form when accompanied by pulmonary atresia (PA). Preserving the patent ductus arteriosus to maintain pulmonary blood flow is life-saving for patients with this congenital heart disease. Milrinone, a selective phosphodiesterase III inhibitor, is a potent vasodilator. Here, we report the successful use of milrinone for a newborn infant with TOF and PA for keeping the ductus arteriosus open and thereby maintaining pulmonary circulation. Milrinone is a useful drug because of its inotropic, lusitropic, and pulmonary vasodilating effects, in addition to its ability to keep the ductus arteriosus open and its relatively mild side-effects. Case series and comparative studies will be needed in the future to verify the effectiveness of this drug.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Tetralogía de Fallot
/
Circulación Pulmonar
/
Atresia Pulmonar
/
Milrinona
/
Conducto Arterial
/
Conducto Arterioso Permeable
/
Fosfodiesterasas de Nucleótidos Cíclicos Tipo 3
/
Cardiopatías
Límite:
Humanos
/
Recién Nacido
Idioma:
Inglés
Revista:
Journal of the Korean Society of Neonatology
Año:
2011
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS